AbbVie Inc.
Close on Nov 2, 2026Market cap $510.41BP/E 81.6Yield 2.30%
AbbVie Adjusted After-Tax Earnings — Non-GAAP by Quarter
Adjusted After-Tax Earnings — Non-GAAP ($M) ($M)
AbbVie Adjusted After-Tax Earnings — Non-GAAP: $6,491M in Q2 2026, up 23.0% from a year earlier.
Where the Q2 2026 figure comes from
“|| As adjusted (non-GAAP) | $ | 7,613 | $ | 6,491 | $ | 3.65”
Source: Form 8-K (abbv-20260630xexhibit991.htm, filed 2026-07-31) ↗
Reported in Form 8-K Non-GAAP Reconciliations.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up adjusted After-Tax Earnings — Non-GAAP
- Reported After-Tax Earnings — GAAP ($M)3,613 · Q2 2026
- Adjusted Pre-Tax Earnings — Non-GAAP ($M)7,613 · Q2 2026
- Reported Pre-Tax Earnings — GAAP ($M)4,278 · Q2 2026
- Adjusted Cost of Products Sold — Non-GAAP ($M)2,598 · Q2 2026
- Adjusted SG&A Expense — Non-GAAP ($M)3,574 · Q2 2026
- Adjusted Income Tax Expense — Non-GAAP ($M)1,119 · Q2 2026
Cite this data
StockData. (2026). AbbVie Adjusted After-Tax Earnings — Non-GAAP ($M), quarterly Q3 2022–Q2 2026 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/nongaap-adj-aftertax
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.